We are continuing to see an increase in the incidence of kidney cancer in younger patients over time. Maintaining kidney health involves basic lifestyle choices: avoiding obesity, not smoking, and ...

With a new online resource, Eisai is offering patients and caregivers some direction to help navigate a kidney cancer ...

During Kidney Cancer Awareness Month, Dr. Eric Singer shares warning signs, risk factors and when younger adults should speak with a doctor about kidney health. March is Kidney Cancer Awareness Month, ...

Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

Built on Insights from Patients and Caregivers, the New Website Curates Trusted Resources from Leading Organizations in Kidney Cancer NUTLEY, N.J., Feb. 26, 2026 /PRNewswire/ -- Eisai Inc. announced ...

DALLAS, Texas (Ivanhoe Newswire) - Kidney cancer is among the 10 most common cancers in both men and women. About 81,000 people will be diagnosed with it this year. A decade ago, advanced kidney ...

A dedicated onconephrology service at Brigham and Women’s Hospital (BWH), Boston, improved acute kidney injury (AKI) recovery rates in patients treated for cancer, according to a preliminary ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center and ...

IceCure Medical (ICCM) announced the completion of its last patients’ five-year follow up evaluation in its ICESECRET ...

DENVER -- A discussion about patient-centered issues in kidney cancer management focused considerable attention on the controversial antiparasitic ivermectin, which was not even on the program at the ...

The NHS spots almost all kidney cancer by accident, a critical report has revealed. Four in five cases of the disease are only being diagnosed when patients have a scan for an unrelated condition or ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center and ...